{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:14:54Z","timestamp":1794834894584,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hyperstimulation syndrome (OHSS). Metformin reduces the risk of OHSS but little is known about the possible effects and mechanisms of action involved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To evaluate whether metformin attenuates some of the ovarian adverse effects caused by OHSS and to study the mechanisms involved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Material and methods<\/jats:title>\n            <jats:p>A rat OHSS model was used to investigate the effects of metformin administration. Ovarian histology and follicle counting were performed in ovarian sections stained with Masson trichrome. Vascular permeability was measured by the release of intravenously injected Evans Blue dye (EB). VEGF levels were measured by commercially immunosorbent assay kit. COX-2 protein expression was evaluated by western blot and NOS levels were analyses by immunohistochemistry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Animals of the OHSS group showed similar physiopathology characteristics to the human syndrome: increased body weight, elevated progesterone and estradiol levels (P&lt;0.001), increased number of corpora lutea (P&lt;0.001), higher ovarian VEGF levels and vascular permeability (P&lt;0.001 and P&lt;0.01); and treatment with metformin prevented this effect (OHSS+M group; P&lt;0.05). The vasoactive factors: COX-2 and NOS were increased in the ovaries of the OHSS group (P&lt;0.05 and P&lt;0.01) and metformin normalized their expression (P&lt;0.05); suggesting that metformin has a role preventing the increased in vascular permeability caused by the syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Metformin has a beneficial effect preventing OHSS by reducing the increase in: body weight, circulating progesterone and estradiol and vascular permeability. These effects of metformin are mediated by inhibiting the increased of the vasoactive molecules: VEGF, COX-2 and partially NOS. Molecules that are increased in OHSS and are responsible for a variety of the symptoms related to OHSS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1757-2215-6-62","type":"journal-article","created":{"date-parts":[[2013,9,8]],"date-time":"2013-09-08T06:16:15Z","timestamp":1378620975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study"],"prefix":"10.1186","volume":"6","author":[{"given":"Evelin M","family":"Elia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Carrere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda V","family":"Bazzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gast\u00f3n","family":"Rey-Valzacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante A","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C","family":"Pustovrh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,8]]},"reference":[{"issue":"5","key":"194_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/molehr\/8.5.409","volume":"8","author":"C Albert","year":"2002","unstructured":"Albert C, Garrido N, Mercader A, Rao CV, Remoh\u00ed J, et al.: The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod 2002,8(5):409\u2013418. 10.1093\/molehr\/8.5.409","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"194_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0015-0282(97)00278-1","volume":"68","author":"CI Friedman","year":"1997","unstructured":"Friedman CI, Danforth DR, Herbosa-Encarnacion C, Arbogast L, Alak BM, et al.: Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril 1997,68(4):607\u2013612. 10.1016\/S0015-0282(97)00278-1","journal-title":"Fertil Steril"},{"issue":"3","key":"194_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/humrep\/del427","volume":"22","author":"D Manau","year":"2007","unstructured":"Manau D, F\u00e1bregues F, Pe\u00f1arrubia J, Creus M, Carmona F, et al.: Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF. Hum Reprod 2007,22(3):669\u2013675.","journal-title":"Hum Reprod"},{"issue":"4, Supplement","key":"194_CR4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.fertnstert.2007.09.028","volume":"90","author":"R Quintana","year":"2008","unstructured":"Quintana R, Kopcow L, Marconi G, Young E, Yovanovich C, et al.: Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model. Fertil Steril 2008,90(4, Supplement):1511\u20131516. 10.1016\/j.fertnstert.2007.09.028","journal-title":"Fertil Steril"},{"issue":"6","key":"194_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1055\/s-0030-1265670","volume":"28","author":"R Gomez","year":"2010","unstructured":"Gomez R, Soares SR, Busso C, Garcia-Velasco JA, Simon C, et al.: Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med 2010,28(6):448\u2013457. 10.1055\/s-0030-1265670","journal-title":"Semin Reprod Med"},{"issue":"8","key":"194_CR6","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1210\/jc.2011-0075","volume":"96","author":"R Gomez","year":"2011","unstructured":"Gomez R, Ferrero H, Delgado-Rosas F, Gaytan M, Morales C, et al.: Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment. J Clin Endocrinol Metab 2011,96(8):2484\u20132492. 10.1210\/jc.2011-0075","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"194_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/PL00005079","volume":"356","author":"E Fujii","year":"1997","unstructured":"Fujii E, Irie K, Ohba K, Ogawa A, Yoshioka T, et al.: Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol 1997,356(4):475\u2013480. 10.1007\/PL00005079","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"194_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/humrep\/dep424","volume":"25","author":"KE Hester","year":"2010","unstructured":"Hester KE, Harper MJK, Duffy DM: Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception. Hum Reprod 2010,25(2):360\u2013367. 10.1093\/humrep\/dep424","journal-title":"Hum Reprod"},{"issue":"2","key":"194_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/humrep\/dep392","volume":"25","author":"C Jesam","year":"2010","unstructured":"Jesam C, Salvatierra AM, Schwartz JL, Croxatto HB: Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception. Hum Reprod 2010,25(2):368\u2013373. 10.1093\/humrep\/dep392","journal-title":"Hum Reprod"},{"issue":"8","key":"194_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, et al.: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001,108(8):1167\u20131174.","journal-title":"J Clin Invest"},{"issue":"28","key":"194_CR11","doi-asserted-by":"publisher","first-page":"25226","DOI":"10.1074\/jbc.M202489200","volume":"277","author":"LGD Fryer","year":"2002","unstructured":"Fryer LGD, Parbu-Patel A, Carling D: The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein Kinase through distinct signaling pathways. J Biol Chem 2002,277(28):25226\u201325232. 10.1074\/jbc.M202489200","journal-title":"J Biol Chem"},{"issue":"42","key":"194_CR12","doi-asserted-by":"publisher","first-page":"43940","DOI":"10.1074\/jbc.M404421200","volume":"279","author":"M-H Zou","year":"2004","unstructured":"Zou M-H, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG, et al.: Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo. J Biol Chem 2004,279(42):43940\u201343951. 10.1074\/jbc.M404421200","journal-title":"J Biol Chem"},{"issue":"6","key":"194_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2011","unstructured":"Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, et al.: Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2011,122(6):253\u2013270.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"194_CR14","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/jc.2011-3061","volume":"97","author":"L Morin-Papunen","year":"2012","unstructured":"Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippelainen M, et al.: Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 2012,97(5):1492\u20131500. 10.1210\/jc.2011-3061","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"194_CR15","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.fertnstert.2011.02.004","volume":"95","author":"EM Elia","year":"2011","unstructured":"Elia EM, Pustovrh C, Amalfi S, Devoto L, Motta AB: Link between metformin and the peroxisome proliferator-activated receptor \u03b3 pathway in the uterine tissue of hyperandrogenized prepubertal mice. Fertil Steril 2011,95(8):2534\u20132537. e1 10.1016\/j.fertnstert.2011.02.004","journal-title":"Fertil Steril"},{"issue":"6","key":"194_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1600-0412.2012.01385.x","volume":"91","author":"GS Ghazeeri","year":"2012","unstructured":"Ghazeeri GS, Nassar AH, Younes Z, Awwad JT: Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstet Gynecol Scand 2012,91(6):658\u2013678. 10.1111\/j.1600-0412.2012.01385.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"194_CR17","volume-title":"Gynecol Endocrinol","author":"J Xiao","year":"2012","unstructured":"Xiao J, Chen S, Zhang C, Chang S: The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol Endocrinol 2012."},{"issue":"4","key":"194_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.fertnstert.2007.07.1385","volume":"90","author":"Z Wei","year":"2008","unstructured":"Wei Z, Cao Y, Cong L, Zhou P, Zhang Z, et al.: Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome. Fertil Steril 2008,90(4):1149\u20131154. 10.1016\/j.fertnstert.2007.07.1385","journal-title":"Fertil Steril"},{"issue":"8","key":"194_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/molehr\/gal057","volume":"12","author":"E Elia","year":"2006","unstructured":"Elia E, Sander V, Luchetti CG, Solano ME, Di Girolamo G, et al.: The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Mol Hum Reprod 2006,12(8):475\u2013481. 10.1093\/molehr\/gal057","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"194_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/molehr\/gap033","volume":"15","author":"EM Elia","year":"2009","unstructured":"Elia EM, Belgorosky D, Faut M, Vighi S, Pustovrh C, et al.: The effects of metformin on uterine tissue of hyperandrogenized BALB\/c mice. Mol Hum Reprod 2009,15(7):421\u2013432. 10.1093\/molehr\/gap033","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"194_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1071\/RD05099","volume":"18","author":"ME Solano","year":"2006","unstructured":"Solano ME, Elia E, Luchetti CG, Sander V, Di Girolamo G, et al.: Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice. Reprod Fertil Dev 2006,18(5):533\u2013544. 10.1071\/RD05099","journal-title":"Reprod Fertil Dev"},{"issue":"6","key":"194_CR22","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.fertnstert.2011.09.020","volume":"96","author":"S Palomba","year":"2011","unstructured":"Palomba S, Falbo A, Carrillo L, Villani MT, Orio F, et al.: Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. Fertil Steril 2011,96(6):1384\u20131390. e4 10.1016\/j.fertnstert.2011.09.020","journal-title":"Fertil Steril"},{"issue":"8","key":"194_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/humrep\/12.8.1629","volume":"12","author":"T Ujioka","year":"1997","unstructured":"Ujioka T, Matsuura K, Kawano T, Okamura H: Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod 1997,12(8):1629\u20131634. 10.1093\/humrep\/12.8.1629","journal-title":"Hum Reprod"},{"issue":"5","key":"194_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3109\/00016341003592537","volume":"89","author":"A Saylan","year":"2010","unstructured":"Saylan A, Arioz DT, Koken T, Dilek H, Saylan F, et al.: Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam. Acta Obstet Gynecol Scand 2010,89(5):692\u2013699. 10.3109\/00016341003592537","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"194_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.mce.2012.10.022","volume":"365","author":"L Scotti","year":"2012","unstructured":"Scotti L, Abramovich D, Pascuali N, de Zuniga I, Oubina A, et al.: Involvement of the ANGPTs\/Tie-2 system in ovarian hyperstimulation syndrome (OHSS). Mol Cell Endocrinol 2012,365(2):223\u2013230.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"194_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mce.2011.01.002","volume":"335","author":"L Scotti","year":"2011","unstructured":"Scotti L, Irusta G, Abramovich D, Tesone M, Parborell F: Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome. Mol Cell Endocrinol 2011,335(2):116\u2013125. 10.1016\/j.mce.2011.01.002","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"194_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1210\/en.2005-0700","volume":"147","author":"Y Kitajima","year":"2006","unstructured":"Kitajima Y, Endo T, Nagasawa K, Manase K, Honnma H, et al.: Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinology 2006,147(2):694\u2013699. Epub 2005 Nov 3.","journal-title":"Endocrinology"},{"issue":"4845","key":"194_CR28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.3125611","volume":"239","author":"TK Woodruff","year":"1988","unstructured":"Woodruff TK, D\u2019Agostino J, Schwartz NB, Mayo KE: Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle. Science 1988,239(4845):1296\u20131299. 10.1126\/science.3125611","journal-title":"Science"},{"issue":"1","key":"194_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1095\/biolreprod66.1.77","volume":"66","author":"G Cheng","year":"2002","unstructured":"Cheng G, Weihua Z, M\u00e4kinen S, M\u00e4kel\u00e4 S, Saji S, et al.: A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod 2002,66(1):77\u201384. 10.1095\/biolreprod66.1.77","journal-title":"Biol Reprod"},{"issue":"31","key":"194_CR30","doi-asserted-by":"publisher","first-page":"11209","DOI":"10.1073\/pnas.0404372101","volume":"101","author":"Y-C Hu","year":"2004","unstructured":"Hu Y-C, Wang P-H, Yeh S, Wang R-S, Xie C, et al.: Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc Natl Acad Sci USA 2004,101(31):11209\u201311214. 10.1073\/pnas.0404372101","journal-title":"Proc Natl Acad Sci USA"},{"key":"194_CR31","first-page":"CD002806","volume":"3","author":"A D\u2019Angelo","year":"2007","unstructured":"D\u2019Angelo A, Amso N: Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2007, 3: CD002806.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"194_CR32","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.fertnstert.2006.11.170","volume":"88","author":"M Isikoglu","year":"2007","unstructured":"Isikoglu M, Berkkanoglu M, Senturk Z, Ozgur K: Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: a prospective randomized placebo-controlled double blind study. Fertil Steril 2007,88(4):982\u2013985. Epub 2007 Feb 20 10.1016\/j.fertnstert.2006.11.170","journal-title":"Fertil Steril"},{"issue":"1","key":"194_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engmann","year":"2008","unstructured":"Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, et al.: The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008,89(1):84\u201391. Epub 2007 Apr 26 10.1016\/j.fertnstert.2007.02.002","journal-title":"Fertil Steril"},{"issue":"4","key":"194_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/humrep\/deq005","volume":"25","author":"C Busso","year":"2010","unstructured":"Busso C, Fernandez-Sanchez M, Garcia-Velasco JA, Landeras J, Ballesteros A, et al.: The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial. Hum Reprod 2010,25(4):995\u20131004. doi:10.1093\/humrep\/deq005. Epub 2010 Feb 6 10.1093\/humrep\/deq005","journal-title":"Hum Reprod"},{"issue":"3","key":"194_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/humrep\/dep436","volume":"25","author":"TG Lainas","year":"2010","unstructured":"Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, et al.: Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Hum Reprod 2010,25(3):683\u2013689. doi:10.1093\/humrep\/dep436Epub. 2009 Dec 15 10.1093\/humrep\/dep436","journal-title":"Hum Reprod"},{"issue":"7","key":"194_CR36","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.01.085","volume":"93","author":"A Varnagy","year":"2010","unstructured":"Varnagy A, Bodis J, Manfai Z, Wilhelm F, Busznyak C, et al.: Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertil Steril 2010,93(7):2281\u20132284. doi:10.1016\/j.fertnstert.2009.01.085. Epub 2009 Mar 3 10.1016\/j.fertnstert.2009.01.085","journal-title":"Fertil Steril"},{"issue":"6","key":"194_CR37","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/humrep\/del025","volume":"21","author":"T Tang","year":"2006","unstructured":"Tang T, Glanville J, Orsi N, Barth JH, Balen AH: The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 2006,21(6):1416\u201325. Epub 2006 Feb 24 10.1093\/humrep\/del025","journal-title":"Hum Reprod"},{"issue":"10","key":"194_CR38","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/humrep\/dei130","volume":"20","author":"S Palomba","year":"2005","unstructured":"Palomba S, Falbo A, Orio F Jr, Manguso F, Russo T, et al.: A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Hum Reprod 2005,20(10):2879\u20132886. Epub 2005 Jun 15 10.1093\/humrep\/dei130","journal-title":"Hum Reprod"},{"issue":"1","key":"194_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.fertnstert.2009.03.081","volume":"92","author":"DR Meldrum","year":"2009","unstructured":"Meldrum DR, Chang RJ, De-Ziegler D, Schoolcraft WB, Scott RT Jr, et al.: Adjuncts for ovarian stimulation: when do we adopt \u201corphan indications\u201d for approved drugs? Fertil Steril 2009,92(1):13\u201318. doi:10.1016\/j.fertnstert.2009.03.081. Epub 2009 May 6 10.1016\/j.fertnstert.2009.03.081","journal-title":"Fertil Steril"},{"issue":"3","key":"194_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/1471-0528.12070","volume":"120","author":"S Palomba","year":"2013","unstructured":"Palomba S, Falbo A, La-Sala GB: Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials. BJOG 2013,120(3):267\u2013276. 10.1111\/1471-0528.12070","journal-title":"BJOG"},{"issue":"2","key":"194_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","volume":"72","author":"V De Leo","year":"1999","unstructured":"De Leo V, la Marca A, Ditto A, Morgante G, Cianci A: Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999,72(2):282\u2013285. 10.1016\/S0015-0282(99)00208-3","journal-title":"Fertil Steril"},{"issue":"6","key":"194_CR42","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1095\/biolreprod.102.010801","volume":"68","author":"R Gomez","year":"2003","unstructured":"Gomez R, Simon C, Remohi J, Pellicer A: Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003,68(6):2164\u20132171.","journal-title":"Biol Reprod"},{"issue":"Suppl 3","key":"194_CR43","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.fertnstert.2004.03.053","volume":"82","author":"HT Ozcakir","year":"2004","unstructured":"Ozcakir HT, Giray SG, Ozbilgin MK, Inceboz US, Caglar H: Effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor in hyperstimulated rat ovary. Fertil Steril 2004,82(Suppl 3):1127\u20131132.","journal-title":"Fertil Steril"},{"issue":"2","key":"194_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0015-0282(97)81520-8","volume":"68","author":"A Lee","year":"1997","unstructured":"Lee A, Christenson LK, Stouffer RL, Burry KA, Patton PE: Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 1997,68(2):305\u2013311. 10.1016\/S0015-0282(97)81520-8","journal-title":"Fertil Steril"},{"key":"194_CR45","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.placenta.2012.07.008","volume":"10","author":"S Haghighi Poodeh","year":"2012","unstructured":"Haghighi Poodeh S, Salonurmi T, Nagy I, Koivunen P, Vuoristo J, et al.: Alcohol-induced premature permeability in mouse placenta-yolk sac barriers in vivo. Placenta 2012, 10: 866\u2013873.","journal-title":"Placenta"},{"issue":"7","key":"194_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.20111343","volume":"209","author":"Z Sun","year":"2012","unstructured":"Sun Z, Li X, Massena S, Kutschera S, Padhan N, et al.: VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med 2012,209(7):1363\u20131377. 10.1084\/jem.20111343","journal-title":"J Exp Med"},{"issue":"1","key":"194_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1742-7843.2008.00234.x","volume":"103","author":"L Solskov","year":"2008","unstructured":"Solskov L, Lofgren B, Kristiansen SB, Jessen N, Pold R, et al.: Metformin induces cardioprotection against ischaemia\/reperfusion injury in the rat heart 24 hours after administration. Basic Clin Pharmacol Toxicol 2008,103(1):82\u201387. 10.1111\/j.1742-7843.2008.00234.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"8","key":"194_CR48","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1158\/1078-0432.CCR-03-0192","volume":"10","author":"F Cianchi","year":"2004","unstructured":"Cianchi F, Cortesini C, Fantappie O, Messerini L, Sardi I, et al.: Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 2004,10(8):2694\u20132704. 10.1158\/1078-0432.CCR-03-0192","journal-title":"Clin Cancer Res"},{"issue":"16","key":"194_CR49","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3748\/wjg.v10.i16.2323","volume":"10","author":"AW Wu","year":"2004","unstructured":"Wu AW, Gu J, Li ZF, Ji JF, Xu GW: COX-2 expression and tumor angiogenesis in colorectal cancer. World J Gastroenterol 2004,10(16):2323\u20132326.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"194_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1479-666X(09)80042-5","volume":"7","author":"DP Toomey","year":"2009","unstructured":"Toomey DP, Murphy JF, Conlon KC: COX-2, VEGF and tumour angiogenesis. Surgeon 2009,7(3):174\u2013180. 10.1016\/S1479-666X(09)80042-5","journal-title":"Surgeon"},{"issue":"5","key":"194_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1593\/neo.11148","volume":"13","author":"R Rattan","year":"2011","unstructured":"Rattan R, Graham RP, Maguire JL, Giri S, Shridhar V: Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia 2011,13(5):483\u2013491.","journal-title":"Neoplasia"},{"issue":"1","key":"194_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","volume":"81","author":"C Ersoy","year":"2008","unstructured":"Ersoy C, Kiyici S, Budak F, Oral B, Guclu M, et al.: The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. Diabetes Res Clin Pract 2008,81(1):56\u201360. doi:10.1016\/j.diabres.2008.02.006 pub 2008 Mar 21 10.1016\/j.diabres.2008.02.006","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"194_CR53","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1262\/jrd.2012-089","volume":"58","author":"J Zhang","year":"2012","unstructured":"Zhang J, Zhang Z, Wu Y, Chen L, Luo Q, et al.: Regulatory effect of hypoxia-inducible factor-1alpha on hCG-stimulated endothelin-2 expression in granulosa cells from the PMSG-treated rat ovary. J Reprod Dev 2012,58(6):678\u2013684. Epub 2012 Aug 20 10.1262\/jrd.2012-089","journal-title":"J Reprod Dev"},{"issue":"6","key":"194_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/jir.2005.25.297","volume":"25","author":"T Hellwig-Burgel","year":"2005","unstructured":"Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W: Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 2005,25(6):297\u2013310. 10.1089\/jir.2005.25.297","journal-title":"J Interferon Cytokine Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-2215-6-62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:46:15Z","timestamp":1630547175000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/1757-2215-6-62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1186\/1757-2215-6-62","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,8]]},"assertion":[{"value":"1 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"62"}}